<DOC>
	<DOCNO>NCT00934908</DOCNO>
	<brief_summary>The purpose study determine take green tea capsule help prevent weight gain patient start therapy Zyprexa® ( olanzapine ) .</brief_summary>
	<brief_title>Prevention Weight Gain Dyslipidemia Green Tea Patients Initiating Therapy With Olanzapine</brief_title>
	<detailed_description>Atypical antipsychotic ( AA ) medication associate obesity , diabetes mellitus , dyslipidemia , cardiovascular disease.1 The prevalence obesity AA medicate population range 40-60 % , compare 30 % general population . Treatments aim either reduce burden obesity psychotic illness prevent weight gain metabolic change associate AA need . One potential therapy receive inadequate clinical evaluation Green tea ( Camillia sinensis ; GT ) . GT contain flavonoid include epigallocatechin gallate ( EGCG ) , well caffeine , document promote weight fat loss normal overweight healthy subject . Recently green tea show significantly decrease plasma LDL triglyceride concentration increase HDL concentration obese woman . GT never evaluate potential prevent weight gain change plasma lipid concentration patient initiate therapy AA . However , case report individual indicate treatment green tea extract may efficacy prevent weight gain 4 patient initiated treatment quetiapine . We hypothesize intake GT form dietary supplement result significantly less weight gain supplementation placebo patient initiate therapy Zyprexa® . We propose conduct 12-week double-blind , placebo-controlled pilot study 48 out-patient volunteer determine twice daily supplementation GT 1 ) attenuates weight fat gain patient initiate therapy Zyprexa® 2 ) attenuates change cardiovascular risk factor include plasma lipoprotein triglyceride concentration . The experiment perform patient initiate therapy Zyprexa® BMI &lt; 40kg/m2 dyslipidemia require pharmacologic intervention .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Weight Gain</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>Concurrently take Zyprexa® psychiatric indication bipolar disorder schizophrenia Stable body weight ( + 5 % ) least 2 week prior baseline visit No weight loss program participation within past 3 month Treatment atypical Antipsychotic treatment olanzapine past 6 month BMI &gt; 40 kg/m2 Use dietary supplement related weight gain weight loss within past 1 month Use medication relate weight plasma lipid concentration ( hormonal contraceptive ) . This include , limited : antihypertensive , benzodiazepine statin , psychostimulants . Uncontrolled hypertension ( SBP &gt; 140 DBP &gt; 90 mmHg ) Use hypertensive medication Known active alcohol substance abuse consumption &gt; three alcoholic beverages/day . Active cardiovascular disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Zyprexa®</keyword>
	<keyword>Green Tea</keyword>
	<keyword>ALL</keyword>
</DOC>